Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?

WHO. Coronavirus Disease 2019 (COVID-19) Situation Report-209 (World Health Organization, Geneva, 2020). Baden, L. R. \u0026 Rubin, E. J. Covid-19—the search for effective therapy. N. Engl. J. Med. 382, 1851–1852 (2020). Article Google Scholar National Health Commission of the People’s Republic of China. Official Guidance for Prevention, Control, Diagnosis and Management for COVID-19 Patients (version 6.0). http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf (2020) (in Chinese). NIH. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines (2020) (NIH, 2020). Shen, C. et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323, 1582–1589 (2020). CAS Article Google Scholar Cheng, Y. et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 24, 44–46 (2005). CAS Article Google Scholar Naranjo-Gomez, M., Lambour, J., Piechaczyk, M. \u0026 Pelegrin, M. Neutrophils are essential for inductionof vaccine-like effects by antiviral monoclonal antibody immunotherapies. JCI Insight 3, e97339 (2018). Article Google Scholar Pelegrin, M., Naranjo-Gomez, M. \u0026 Piechaczyk, M. Antiviral monoclonal antibodies: can they be more than simple neutralizing agents? Trends Microbiol. 23, 653–665 (2015). CAS Article Google Scholar Nasser, R., Pelegrin, M., Plays, M., Gros, L. \u0026 Piechaczyk, M. Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies. Blood 121, 1102–1111 (2013). CAS Article Google Scholar von Behring, H. On the occasion of the 100th birthday of Emil von Behring. Dtsch. Med. J. 5, 172–173 (1954). Google Scholar Mair-Jenkins, J. et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J. Infect. Dis. 211, 80–90 (2015). CAS Article Google Scholar World Health Organization MERS-CoV Research Group. State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans. PLoS. Curr. https://doi.org/10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 (2013). Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 179, S18–S23 (1999). Article Google Scholar Dean, N. E. et al. Creating a framework for conducting randomized clinical trials during disease outbreaks. N. Engl. J. Med. 382, 1366–1369 (2020). Article Google Scholar Smatti, M. K., Thani, A. A. \u0026 Yassine, H. M. Viral-induced enhanced disease illness. Front. Microbiol. 9, 2991 (2018). Article Google Scholar Yong, C. Y., Ong, H. K., Yeap, S. K., Ho, K. L. \u0026 Tan, W. S. Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus. Front. Microbiol. 10, 1781 (2019). Article Google Scholar Fu, Y. J., Cheng, Y. X. \u0026 Wu, Y. T. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol. Sin. 35, 266–271 (2020). CAS Article Google Scholar Ulrich, H., Pillat, M. M., Tarnok, A. \u0026 Dengue Fever, COVID-19 (SARS-CoV-2), and antibody- dependent enhancement (ADE): a perspective. Cytom. A. 97, 662–667 (2020). CAS Article Google Scholar Eroshenko, N. et al. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nat. Biotechnol. 38, 789–791 (2020). CAS Article Google Scholar Luke, T. C. et al. Hark back: passive immunotherapy for influenza and other serious infections. Crit. Care. Med. 38, e66–e73 (2010). Article Google Scholar Nie, J. et al. Establishment and validation of a pseudo-virus neutralization assay for SARS-CoV-2. Emerg. Microbes Infect. 9, 680–686 (2020). CAS Article Google Scholar Yeh, K. M. et al. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J. Antimicrob. Chemother. 56, 919–922 (2005). CAS Article Google Scholar Wong, H. K. et al. Practical limitations of convalescent plasma collection:a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion 50, 1967–1971 (2010). Article Google Scholar Download references The author gratefully acknowledges the staff of the Department of Immunology in Fifth Medical Center for submitting literature potentially relevant to this perspective. Heartfelt thanks are also given to Drs. Smatti MK, Al Thani AA, and Yassine HM of Biomedical Research Center, Qatar University, Doha, Qatar for their paper’ fig. 1 a, b. Department of Immunology and National Center for Biomedicine Analysis, Fifth Medical Center of Chinese PLA General Hospital, No. 8, Dongda Ave, Fengtai District, 100071, Beijing, P.R. China Yongzhi Xi You can also search for this author in PubMed Google Scholar X.Y. conceived the study, analyzed the data, and wrote the first draft and final paper. Correspondence to Yongzhi Xi. The author declares no competing interests. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the...